Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) EPS (Weighted Average and Diluted): 2021-2023

Historic EPS (Weighted Average and Diluted) for Therapeutics (RAPT) over the last 3 years, with Dec 2023 value amounting to -$3.05.

  • Therapeutics' EPS (Weighted Average and Diluted) fell 24.62% to -$0.81 in Q4 2023 from the same period last year, while for Dec 2023 it was -$3.05, marking a year-over-year decrease of 17.76%. This contributed to the annual value of -$3.05 for FY2023, which is 18.22% down from last year.
  • According to the latest figures from FY2023, Therapeutics' EPS (Weighted Average and Diluted) is -$3.05, which was down 18.22% from -$2.58 recorded in FY2022.
  • In the past 5 years, Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of -$2.53 in FY2021 and a low of -$3.05 during FY2023.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$2.58 (2022), whereas its average is -$2.72.
  • Data for Therapeutics' EPS (Weighted Average and Diluted) shows a maximum YoY fell of 18.22% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Therapeutics' EPS (Weighted Average and Diluted) stood at -$2.53 in 2021, then fell by 1.98% to -$2.58 in 2022, then declined by 18.22% to -$3.05 in 2023.